Droxi vs Elaborate (2026)
Two inbox products that both go further than drafting replies, and Elaborate goes furthest. Droxi reads each inbound item against the patient's full record before proposing an action, running natively in the record system with an honest boundary: primary care, three item types, nothing more. Elaborate holds the deepest integration position in this category by a clear margin, the broadest evidenced setting coverage, the strongest oversight description and the best security disclosure surface here, though it publishes no price at all. For a primary care practice wanting a bounded product that works inside the chart, Droxi is the smaller commitment. For a health system replacing inbox infrastructure across settings, Elaborate is the more complete platform. Neither publishes a mistriage rate.
- It reads every inbound item against the patient's full record rather than against the message alone, which is what separates triage from keyword routing.
- It runs natively inside the record system with no separate login, and is listed on a major record system marketplace rather than only claiming integration.
- Scope is stated plainly as primary care and three item types, which is an honest boundary rather than a claim to work the whole inbox.
- The deepest integration position in this category and the only vendor here reaching that far into the record, with the broadest evidenced setting coverage.
- The strongest oversight position in the category, with tiered handling described rather than implied.
- It names its mechanism where competitors describe capability, and runs a live public security disclosure surface.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Droxi and Elaborate are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Droxi | Elaborate |
|---|---|---|
| Primary category | Clinical Inbox & Messaging AI | Clinical Inbox & Messaging AI |
| Founded | Not recorded | 2021 |
| Headquarters | Tel Aviv, Israel | New York, New York |
| Website | droxi.com | elaborate.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Droxi its top capability grade on AI Centrality. Set against Elaborate, Droxi grades higher on AI Centrality. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Elaborate its top capability grade on EHR and Interoperability Depth and Setting and Specialty Coverage. Set against Droxi, Elaborate grades higher on several axes, including Model and Technology Transparency, Security Certifications and Trust Center and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Droxi or Elaborate?
On the axes where the AI Health Index separates them, Droxi grades higher on AI Centrality, and Elaborate grades higher on several axes, including Model and Technology Transparency, Security Certifications and Trust Center and EHR and Interoperability Depth. Elaborate leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Droxi and Elaborate differ most?
The widest separation the AI Health Index records between Droxi and Elaborate is on AI Centrality, where Droxi grades A and Elaborate grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Droxi and Elaborate grade the same?
The AI Health Index grades Droxi and Elaborate the same on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Inbox & Messaging AI page.
The decisive failure in this category is mistriage, an urgent clinical signal sitting inside a routine looking message, and neither vendor publishes how often it happens or what proportion of generated drafts clinicians send unedited. Neither publishes a subgroup or language performance analysis, which matters because triage quality varies with how a patient writes, and patients with lower health literacy or writing in a second language are the ones most likely to be misrouted. Neither publishes pricing, and every commercial path routes through a demo.